The EPS projection of CDK Global, Inc. (NASDAQ:CDK) for quarter ended 2016-09-30 is $0.52. Last week, the EPS forecast was $0.52 against target of $0.52, a month earlier. Two months ago, this estimate was $0.52 versus forecast of $0.52 three months earlier, implying a deviation of 0%.
CDK Global, Inc. (NASDAQ:CDK) stated that 18 days ago, its stock price was positively revised 3 times while negative revisions were 0.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 1 , 1, 1, and 1, correspondingly.
EPS estimate downgrade for CDK Global, Inc. (NASDAQ:CDK) in the preceding 30, 120, 60 and 90 days were 0, 0, 0, and 0, correspondingly.
CDK Global, Inc. (NASDAQ:CDK) EPS target for the quarter closed 3 was $0.52, based on 4 recommendations. As reported on 2016-05-05 the EPS was $0.42. The change was $0.01, implying a percentage deviation of 2.44%. The projections showed a standard deviation of 0.01.
Quarterly Sales Estimates
CDK Global, Inc. (NASDAQ:CDK) yearly sales prediction for the fiscal 2017 stands at $563.38 and the median estimate is at $563.38. Almost 2 analysts issued sales target.
Highest sales target is $576 while the lowest target is $550.76 showing standard deviation of 17.847%.
As many as 2 analysts have sales targets revised upside while 2 reduced sales estimates, implying a deviation of 0%.
Last month, 2 revised sales number projection on upside while 2 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast. CDK Global, Inc. (NASDAQ:CDK) announced that the deviation in forecast was -0.274%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...